ICCM IceCure Medical Ltd. - Ordinary Shares
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Mar 17, 2026
$1.57
· of 52w range
· above low
· to high
$0.2252w low
$9.5452w high
Market Cap
$115M
P/E
6.5
EPS
$0.24
Revenue
$3M
your badges
52W Range
$0–$10
Analyst Rating
BUY
Price Target
$23
P/E
6.5
ROE
-188.8%
Net Profit Margin
-445.6%
Your badge strip is empty — pin a metric anywhere on this page.
ICCM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.57
Market Cap
$115M
P/E
6.5
EPS
$0.24
Revenue
$3M
ROE
-188.8%
Debt/Equity
0.0
52W Range
$0–$10
ICCM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| June 4, 2026 | 1-for-30 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$3M2019-12-31 → 2025-12-31
EPS$0.242019-12-31 → 2025-12-31
Free Cash Flow$-15M2021-12-31 → 2025-12-31
Net margin-445.6%2021-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ICCM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | 6.55Y avg ≈4.3 | ≈4.3 | · | · | |
| P/S | 34.05Y avg ≈19.3 | ≈19.3 | · | · | |
| P/B | 12.75Y avg ≈5.0 | ≈5.0 | · | · | |
| EV / EBITDA | -7.0 | · | · | · | |
| Price / FCF | -7.95Y avg ≈-5.0 | ≈-5.0 | · | · | |
| Price / Cash Flow | -7.95Y avg ≈-5.1 | ≈-5.1 | · | · | |
| EV / Revenue | 31.3 | · | · | · | |
| EV / FCF | -7.2 | · | · | · | |
| Price / Tangible Book | 12.75Y avg ≈5.0 | ≈5.0 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | ICCM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | 36.3%5Y avg ≈44.1% | ≈44.1% | · | · | |
| Operating Margin | -446.7%5Y avg ≈-436.7% | ≈-436.7% | · | · | |
| EBITDA Margin | -446.7%5Y avg ≈-436.7% | ≈-436.7% | · | · | |
| Net Profit Margin | -445.6%5Y avg ≈-430.9% | ≈-430.9% | · | · | |
| ROA | -113.8%5Y avg ≈-76.7% | ≈-76.7% | · | · | |
| ROE | -188.8%5Y avg ≈-110.6% | ≈-110.6% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ICCM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity | 0.0 | · | · | · | |
| Current Ratio | 2.65Y avg ≈4.5 | ≈4.5 | · | · | |
| Quick Ratio | 1.95Y avg ≈3.6 | ≈3.6 | · | · | |
| Long-Term Debt / Equity | 0.0 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | ICCM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.35Y avg ≈0.2 | ≈0.2 | · | · | |
| Inventory Turnover | 0.95Y avg ≈1.0 | ≈1.0 | · | · | |
| Receivables Turnover | 12.25Y avg ≈19.0 | ≈19.0 | · | · | |
| Revenue / Employee | ≈$50.4K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-24.0%
Next Report
Nov 02, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 12, 2026 | $-3.11 | $-1.53 | -103.3% |
| March 31, 2026 | May 14, 2026 | $-1.80 | $-1.43 | -26.0% |
| Dec. 31, 2025 | $-2.10 | $-1.38 | -52.5% | |
| Sept. 30, 2025 | $-1.80 | $-1.53 | -17.6% | |
| June 30, 2025 | $-1.80 | $-1.99 | 9.5% | |
| March 31, 2025 | $-0.06 | $-0.08 | 26.5% | |
| Dec. 31, 2024 | $-0.08 | $-0.08 | -4.6% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $3M | $3M | $3M | $3M | $4M | $4M | |
| Cost of Revenue | $2M | $2M | $2M | $2M | $2M | $1M | |
| Gross Profit | $1M | $1M | $1M | $1M | $2M | $2M | |
| R&D Expense | $7M | $7M | $8M | $9M | $6M | $4M | |
| SG&A Expense | $5M | $4M | $4M | $6M | $4M | $120.0K | |
| Operating Income | $-15M | $-16M | $-16M | $-17M | $-10M | $-4M | |
| Other Non-op | $37.0K | $378.0K | $924.0K | $-239.0K | $-171.0K | $412.0K | |
| Net Income | $-15M | $-15M | $-15M | $-17M | $-10M | $-4M | |
| EPS (Basic) | $0.24 | $0.30 | $0.32 | $0.46 | $0.35 | $0.22 | |
| EPS (Diluted) | $0.24 | $0.30 | $0.32 | $0.46 | $0.35 | $0.22 | |
| Shares (Basic) | 63,579,251 | 50,876,790 | 45,638,030 | 37,016,631 | 28,548,676 | 17,128,903 | |
| Shares (Diluted) | 63,579,251 | 50,876,790 | 45,638,030 | 37,016,631 | 28,548,676 | 17,128,903 | |
| EBITDA | $-15M | $-16M | $-16M | $-17M | $-10M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $8M | $11M | $24M | $26M | $4M | |
| Short-term Investments | · | · | $529.0K | · | · | · | |
| Receivables | $331.0K | $221.0K | $103.0K | $78.0K | $456.0K | $94.0K | |
| Inventory | $3M | $2M | $2M | $3M | $2M | $1M | |
| Prepaid Expense | $752.0K | $981.0K | $744.0K | $1M | · | · | |
| Current Assets | $13M | $11M | $14M | $28M | $30M | $10M | |
| PP&E (Net) | $993.0K | $1M | $2M | $1M | $713.0K | $307.0K | |
| PP&E (Gross) | $3M | $3M | $3M | $2M | $1M | $478.0K | |
| Accum. Depreciation | $2M | $2M | $1M | $906.0K | $298.0K | $171.0K | |
| Total Assets | $14M | $13M | $16M | $30M | $32M | $10M | |
| Accounts Payable | · | · | $502.0K | $714.0K | $881.0K | $645.0K | |
| Current Liabilities | $5M | $6M | $4M | $4M | $4M | $4M | |
| Capital Leases | · | $161.0K | $376.0K | $430.0K | $685.0K | $118.0K | |
| Total Debt | $13.0K | · | · | · | · | · | |
| Paid-in Capital | · | $112M | $102M | $101M | $85M | $54M | |
| Retained Earnings | $-120M | $-105M | $-90M | $-75M | $-58M | $-49M | |
| Treasury Stock | · | · | · | · | · | $41.0K | |
| Stockholders' Equity | $9M | $7M | $12M | $25M | $27M | $6M | |
| Liabilities + Equity | $14M | $13M | $16M | $30M | $32M | $10M | |
| Shares Outstanding | 73,122,293 | 56,568,999 | 45,729,684 | 45,623,434 | 35,780,335 | 20,218,220 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $869.0K | $1M | $2M | $316.0K | $229.0K | |
| Operating Cash Flow | $-15M | $-13M | $-13M | $-14M | $-13M | $-4M | |
| CapEx | $36.0K | $71.0K | $480.0K | $891.0K | $533.0K | $223.0K | |
| Investing Cash Flow | $-36.0K | $446.0K | $-684.0K | $-891.0K | $4M | $-5M | |
| Stock Issued | · | $9M | · | $14M | $15M | $6M | |
| Net Stock Activity | · | $9M | · | $14M | $15M | · | |
| Financing Cash Flow | $16M | $9M | $83.0K | $14M | $31M | $6M | |
| Net Change in Cash | · | · | · | $-2M | $22M | $-3M | |
| Free Cash Flow | $-15M | $-13M | $-13M | $-15M | $-13M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 36.3% | 44.1% | 40.3% | 46.8% | 53.0% | · | |
| Operating Margin | -446.7% | -476.9% | -482.4% | -542.6% | -235.0% | · | |
| Net Margin | -445.6% | -465.4% | -453.8% | -550.3% | -239.1% | · | |
| EBITDA Margin | -446.7% | -476.9% | -482.4% | -542.6% | -235.0% | · | |
| ROA | -113.8% | -105.7% | -62.9% | -54.4% | -46.5% | · | |
| ROE | -188.8% | -160.7% | -78.0% | -64.8% | -60.7% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 2.6 | 2.0 | 3.7 | 6.5 | 7.5 | · | |
| Quick Ratio | 1.9 | 1.4 | 2.9 | 5.5 | 6.5 | · | |
| Debt / Equity | 0.0 | · | · | · | · | · | |
| LT Debt / Equity | 0.0 | · | · | · | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | 0.1 | 0.1 | 0.2 | · | |
| Inventory Turnover | 0.9 | 0.9 | 0.8 | · | 1.3 | · | |
| Receivables Turnover | 12.2 | 20.3 | 35.7 | 11.6 | 15.0 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.12 | $0.12 | $0.27 | $0.56 | $0.75 | · | |
| Revenue / Share | $0.05 | $0.06 | $0.07 | $0.08 | $0.14 | · | |
| Cash Flow / Share | $-0.23 | $-0.25 | $-0.27 | $-0.39 | $-0.44 | · | |
| Cash / Share | $0.12 | $0.13 | $0.23 | $0.52 | $0.72 | · | |
| EPS (TTM) | $0.24 | $0.30 | $0.32 | $0.46 | $0.35 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $3M | $3M | $3M | $4M | · | |
| Net Income TTM | $-15M | $-15M | $-15M | $-17M | $-10M | · | |
| Market Cap | $45M | $62M | $49M | $71M | $109M | · | |
| Enterprise Value | $36M | · | · | · | · | · | |
| P/E | 2.5 | 3.7 | 3.3 | 3.4 | 8.7 | · | |
| P/S | 13.2 | 18.9 | 15.2 | 22.9 | 26.4 | · | |
| P/B | 4.9 | 9.0 | 4.0 | 2.8 | 4.0 | · | |
| P / Tangible Book | 4.9 | 9.0 | 4.0 | 2.8 | 4.0 | · | |
| P / Cash Flow | -3.1 | -5.0 | -3.9 | -4.9 | -8.7 | · | |
| P / FCF | -3.1 | -4.9 | -3.8 | · | -8.3 | · | |
| EV / EBITDA | -2.4 | · | · | · | · | · | |
| EV / FCF | -2.4 | · | · | · | · | · | |
| EV / Revenue | 10.6 | · | · | · | · | · | |
| Earnings Yield | 39.3% | 27.3% | 29.9% | 29.7% | 11.5% | · |
Per Share
| Metric | Trend | Q4 2022 |
|---|---|---|
| EPS (TTM) | $0.46 |
Valuation (TTM)
| Metric | Trend | Q4 2022 |
|---|---|---|
| Revenue TTM | $3M | |
| Net Income TTM | $-17M | |
| P/E | 3.4 | |
| Earnings Yield | 29.7% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $3M | $3M | $3M | $3M | $4M |
| Gross Margin % | 36.3% | 44.1% | 40.3% | 46.8% | 53.0% |
| Operating Margin % | -446.7% | -476.9% | -482.4% | -542.6% | -235.0% |
| Net Income | $-15M | $-15M | $-15M | $-17M | $-10M |
| Diluted EPS | $0.24 | $0.30 | $0.32 | $0.46 | $0.35 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 0.0 | · | · | · | · |
| Current Ratio | 2.6 | 2.0 | 3.7 | 6.5 | 7.5 |
| Quick Ratio | 1.9 | 1.4 | 2.9 | 5.5 | 6.5 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-15M | $-13M | $-13M | $-15M | $-13M |
Institutional owners (13F)
Institutional activity — Q1 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 5 (0 vs prior Q) | 6 (+3 vs prior Q) | 4 (+2 vs prior Q) | 0 (-2 vs prior Q) | +2.7M |
Compared to Q4 2025. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Mr. Li Haixiang, Epoch Partner Investments Limited | March 27, 2026 | 45.80% | Amendment | · | SEC |
| Epoch Partner Investments Limited, Mr. Li Haixiang | May 14, 2025 | 45.70% | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 5 insiders · 0 officers · 0 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Meir Peleg | · | Aug. 14, 2026 A | 194,816 | 0 | 0 | $0 |
| Merav Nir Dotan | · | Aug. 14, 2026 A | 76,168 | 0 | 0 | $0 |
| Shay Levav | · | Aug. 14, 2026 A | 146,303 | 0 | 0 | $0 |
| Shad Good | · | Aug. 14, 2026 A | 136,698 | 0 | 0 | $0 |
| Tlalit Bussi Tel-Tzure | · | Aug. 14, 2026 A | 106,518 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ICCM Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 9 analysts
BUY
Median target
$28.00
+1683.4%
2 22.2%
Strong Buy
6 66.7%
Buy
1 11.1%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
3 analysts · 2026-09-29Mean target $22.67 +1343.7%
← Below all targets
Current price $1.57
Low$10.00
Mean$22.67
High$30.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ICCM | $45M | 2.5 | · | -445.6% | -188.8% | 36.3% |
| LFWD | $879.6K | -0.0 | -14.1% | -90.4% | -169.3% | 38.2% |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Mar 17, 2026